Two Sigma Securities’s Werewolf Therapeutics HOWL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19K Buy
+20,578
New +$13.1K ﹤0.01% 1502
2025
Q3
– Sell
-22,409
Closed -$24.4K – 1662
2025
Q2
$24.4K Buy
+22,409
New +$23.1K ﹤0.01% 1180
2025
Q1
– Sell
-12,740
Closed -$18.9K – 1775
2024
Q4
$18.9K Buy
+12,740
New +$26K ﹤0.01% 1331

Other funds holding HOWL

Two Sigma Securities's HOWL Position: Q3 2026 in Review

Two Sigma Securities opened a new position in Werewolf Therapeutics (HOWL) in Q3 2026: 20,578 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #1502 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in HOWL as recently as Q2 2025.

Two Sigma Securities first reported a position in HOWL in Q4 2024 and has held it in 3 quarters since. The position peaked at $24.4K in Q2 2025. 46 funds tracked by Wall St. Rank hold HOWL as of Q3 2026.

  • Two Sigma Securities held 20,578 shares of Werewolf Therapeutics worth $19K as of Q3 2026.
  • Werewolf Therapeutics was a new Two Sigma Securities position in Q3 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q3 2026, its #1502 holding.
  • Two Sigma Securities first reported a position in Werewolf Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Two Sigma Securities's Werewolf Therapeutics position peaked at $24.4K in Q2 2025.
  • 46 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q3 2026.

Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.